Terumo pays $2.6 billion for US blood-processing firm

Japanese firms continue on the M&A trail with Terumo entering a $2.6 billion deal to buy US blood-processing technologies company CaridianBCT from its Swedish owners.

Terumo Medical Corporation has bought CaridianBCT for $2.63 billion, in the latest of a series of cross-border acquisitions by Japanese healthcare firms.

CaridianBCT started life as the blood-related division of a Swedish company called Gambro, which was bought in 2006 by Investor AB, a Nordic-based industrial-holding and private-equity firm. A year later, it restructured Gambro into three separate companies, one of which was Colorado-based CaridianBCT.

In the deal struck with Investor, Terumo has agreed to take on CaridianBCT with the debt on its books for an enterprise value of $2.63 billion, which translates to a multiple of 15 times trailing 2010...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222